Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is a publicly traded Healthcare sector company. As of May 21, 2026, OBIO trades at $3.98 with a market cap of $238.33M and a P/E ratio of -3.57. OBIO moved +0.13% today. Year to date, OBIO is -6.13%; over the trailing twelve months it is +34.92%. Its 52-week range spans $2.20 to $6.50. Analyst consensus is strong buy with an average price target of $13.40. Rallies surfaces OBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own OBIO include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Orchestra BioMed Holdings, Inc. Ordinary Shares.
| Metric | Value |
|---|---|
| Price | $3.98 |
| Market Cap | $238.33M |
| P/E Ratio | -3.57 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.50 |
| 52-Week Low | $2.20 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $33.48M |
| Net Income | $-52.70M |
| Gross Margin | 99.43% |
6 analysts cover OBIO: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.40.